Karyopharm Therapeutics
KPTI • NASDAQ • Stock Fundamentals
Karyopharm Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard A. Paulson, with a market cap of $204.0M.
Market Cap$204.0M
Employees325.0
CEORichard A. Paulson
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 1 month agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Karyopharm Therapeutics FAQ
Common questions about Karyopharm Therapeutics
Karyopharm Therapeutics (KPTI) has a market capitalization of $204.0M and trades on NASDAQ.
Karyopharm Therapeutics has approximately 325 employees.